Form 4: Hinge Health CFO Sells Shares for Tax Obligations

Hinge Health's Chief Financial Officer, James Budge, disposed of 3,036 shares of Class A Common Stock to cover tax liabilities related to vested restricted stock units.

Summary

• James Budge, Chief Financial Officer of Hinge Health, Inc. (HNGE), reported a disposition of Class A Common Stock.
• The transaction involved 3,036 shares disposed of on February 1, 2026.
• The shares were disposed of at a price of $34.9 per share.
• This was an exempt transaction (Code F) pursuant to Section 16b-3(e), specifically for the payment of tax liability incident to the vesting of restricted stock units.
• Following this transaction, James Budge beneficially owns 434,895 shares of Class A Common Stock directly.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It is a routine, pre-planned transaction for tax purposes related to executive compensation and does not indicate a change in the company's fundamental outlook or the insider's confidence.

Positives

• The transaction is a routine tax-related sale, indicating the vesting of restricted stock units, which is a form of compensation for the CFO.

Negatives

• No specific negative implications are evident from this routine tax-related disposition of shares.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports an insider transaction.

Management Comments

• All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to tax withholding from RSU vesting, are common and generally do not reflect a change in management's outlook on the company's prospects. The use of a Rule 10b5-1 plan for this transaction indicates a pre-arranged sale, further reducing its signaling impact.

Related Party Transactions

• The transaction involves the disposition of shares by a Chief Financial Officer to the issuer (Hinge Health, Inc.) to cover tax obligations arising from vested restricted stock units, which is a standard compensation-related dealing between an executive and their company.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, tax-related insider sale and does not suggest a change in the company's operational or financial health.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled disposition of shares by the CFO to cover tax liabilities from vested restricted stock units. Such transactions are common and generally do not signal a change in the company's fundamentals or the insider's long-term view. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new information to alter an investment thesis.

Keywords

Hinge Health, HNGE, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, James Budge, CFO, 10b5-1 Plan